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Abstract
Hematopoietic stem cell (HSC) homeostasis in the adult bone marrow (BM) is regulated by both intrinsic gene expression
products and interactions with extrinsic factors in the HSC niche. GRP94, an endoplasmic reticulum chaperone, has been
reported to be essential for the expression of specific integrins and to selectively regulate early T and B lymphopoiesis. In
GRP94 deficient BM chimeras, multipotent hematopoietic progenitors persisted and even increased, however, the
mechanism is not well understood. Here we employed a conditional knockout (KO) strategy to acutely eliminate GRP94 in
the hematopoietic system. We observed an increase in HSCs and granulocyte-monocyte progenitors in the Grp94 KO BM,
correlating with an increased number of colony forming units. Cell cycle analysis revealed that a loss of quiescence and an
increase in proliferation led to an increase in Grp94 KO HSCs. This expansion of the HSC pool can be attributed to the
impaired interaction of HSCs with the niche, evidenced by enhanced HSC mobilization and severely compromised homing
and lodging ability of primitive hematopoietic cells. Transplanting wild-type (WT) hematopoietic cells into a GRP94 null
microenvironment yielded a normal hematology profile and comparable numbers of HSCs as compared to WT control,
suggesting that GRP94 in HSCs, but not niche cells, is required for maintaining HSC homeostasis. Investigating this, we
further determined that there was a near complete loss of integrin a4 expression on the cell surface of Grp94 KO HSCs,
which showed impaired binding with fibronectin, an extracellular matrix molecule known to play a role in mediating HSC-
niche interactions. Furthermore, the Grp94 KO mice displayed altered myeloid and lymphoid differentiation. Collectively, our
studies establish GRP94 as a novel cell intrinsic factor required to maintain the interaction of HSCs with their niche, and thus
regulate their physiology.
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Introduction
In theadult hematopoietic system,hematopoietic stem cell(HSC)
regulation of self-renewal and differentiation is at both the intrinsic
and extrinsic level, and is tightly regulated under physiological
conditions [1,2]. HSCs reside in a specific anatomic location in the
bone marrow (BM) known as the stem cell niche [3,4]. Signaling
cues from neighboring cells in the niche are key in dictating the
function of the cell to maintain the hematopoietic system of the
individual [5–7]. At the endosteal surface [8], which is the interface
between bone and the BM, specialized osteoblasts represent the
main components of HSC niche [9,10]. It has been proposed that
this heterogeneous group of cells regulates HSC survival, self-
renewal, migration, differentiation, and quiescence [11,12] through
severalsoluble factors and their receptors such asangiopoietin/Tie2
[13], osteopontin [14,15] and Ca
2+/CaR [16], as well as direct
contact through extracellular matrix and cell surface proteins
[17,18], such as integrins [19,20]. HSC engraftment is a multistep
process involving homing, transmarrow migration, and lodging
within the BM niche [15], all of which is controlled by adhesion
molecules, soluble ligands and their receptors [3].
It is also clear that the decision of the HSC to self-renew or
differentiate is dependent upon the extrinsic signaling mecha-
nisms controlling the expression of intrinsic determinants of
HSC function. Previous studies have determined that a number
of cell cycle regulators [1,21] such as the early G1-phase
checkpoint regulator p18
INK4C [22], and the later G1-phase
checkpoint regulator P21
cip1/waf1 [23], are critical to maintain
HSC quiescence. Retinoblastoma family protein [24] and
PTEN [25,26] also play crucial roles in maintaining HSC
homeostasis. Transcription factors such as Zinc-finger repressor
Gfi1 [27,28] and chromatin-associated factors like Bmi1 [29]
have been implicated as key regulators in maintaining HSC
self-renewal.
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e20364Glucose-regulated protein 94 (GRP94; also referred to as gp96,
CaBP4, endoplasmin, Tra-1) is a metazoan-restricted member of
the HSP90 protein family. It is traditionally regarded as an
endoplasmic reticulum (ER) localized chaperone assisting in
protein folding, assembly and secretion [30]. Due to its client
selectivity and interactions with late folding intermediates, GRP94
is postulated to perform unique chaperone functions in the ER,
and control specific pathways critical for cell growth and
differentiation [31]. In Drosophila, Gp93 (ortholog of GRP94) is
required for gut epithelial homeostasis and nutrient assimilation-
coupled growth control, suggesting an essential role in the
functional expression of specific secretory/integral membrane
proteins in tissue specialization [32]. Loss of GRP94 function in
mouse models revealed that it is required for mouse embryonic
development [33] and plays an important role in immune
functions [34–36]. For example, GRP94 is required for the
expression of a large number of integrins, as well as Toll-like
receptors and selectively regulates innate immunity of macro-
phages [37,38], and early T and B lymphopoiesis [39,40].
Furthermore, using a BM chimeric approach, an increase in
HSCs and multipotent progenitors was observed in BM devoid of
GRP94 [40], raising the interesting issue of how GRP94 deficiency
could lead to HSC expansion.
Recently, we described the creation of a floxed mouse model of
GRP94 targeting the exon 2 of the Grp94 allele (Grp94
F/F) for
examining GRP94 function in specific tissues [41,42]. We report
here that by breeding the Grp94
F/F mice with the transgenic mice
expressing Mx-1 promoted Cre recombinase [43], we generated
Grp94
F/F; Mx-1-Cre (referred to below as cKO) mice that allows
inducible, acute homozygous knockout (KO) of GRP94 in the
hematopoieticsystemthroughinjectionofpolyinosinic-polycytidylic
acid (pI.pC). GRP94 deficiency results in a striking 2-fold
expansion of the HSC-enriched Lin
2 c-Kit
+ Sca-1
+ (LSK) cell
population (p,0.001) with increases in both the long-term (LT)
and short-term (ST) HSC populations. Cell cycle analysis showed
loss of quiescence and lodgment assays revealed impaired HSC-
niche interaction as a major contributing factor for this increase.
Through transplantation assays we further determined that this is
a HSC cell autonomous effect, which can be mediated by the loss
of integrin a4 expression on the cell surface of Grp94 KO HSCs,
leading to impaired HSC retention in the niche. Collectively, our
studies establish GRP94 as a novel cell intrinsic factor required to
maintain the interaction of HSCs with their niche, and thus
regulate their physiology.
Results
Creation of a mouse model with inducible knockout of
Grp94 in the hematopoietic system
To study the in vivo function of GRP94, we created Grp94
mutant mice with the floxed or knockout allele (Figure 1A).
Deletion of exon 2 flanked by the loxP-FRT sites led to an early
frameshift mutation resulting in the inactivation of the Grp94 allele.
To determine the role of GRP94 in the hematopoietic system, we
bred Grp94
F/F mice with transgenic mice bearing the Mx-1-Cre
transgene that allows GRP94 to be acutely eliminated in the
hematopoietic system in an inducible manner by administration of
pI.pC. In these studies, Grp94 was deleted in 5.5 to 6.5 week old
Grp94
F/F; Mx-1-Cre (referred to below as cKO) mice. Littermates
lacking the Cre transgene (Grp94
F/F), which are phenotypically
equivalent to animals with wild-type (WT) Grp94 alleles, were also
injected with pI.pC and served as controls for any side effects of
Figure 1. Conditional knockout of Grp94 in the bone marrow. A) Schematic drawings of the Grp94 wild-type (WT) allele, the floxed allele and
the knockout (KO) allele. The exons are boxed and numbered. The loxP sites (closed triangle) and the FRT site (open triangle) and expected PCR
products for genotyping is indicated. B) Representative BM PCR genotyping results of mice with indicated genotypes after pI.pC injection. C) Grp94
mRNA expression measured by quantitative real-time PCR from WT (n=16) and cKO (n=18) mouse BM after pI.pC injection. The level of Grp94 mRNA
was normalized against the level of internal control 18S RNA. The data are presented as mean 6 s.e., ***p,0.001.
doi:10.1371/journal.pone.0020364.g001
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as WT mice. The status of the Grp94 allele deletion was validated
by PCR in isolated BM cells (Figure 1B). Real-time quantitative
PCR analysis with mouse BM cells 11 days after 7 shots of pI.pC
injection showed that Grp94 transcripts were mostly depleted from
the BM cells of the cKO mice (Figure 1C).
GRP94 deficiency expands primitive cell pool through
loss of quiescence
In analyzing the effect of acute Grp94 deletion on primitive
hematopoietic cells, we observed that within 3 weeks of GRP94
depletion there was an expansion of the most primitive Lin
2 c-
Kit
+ Sca-1
+ Flk2
2 CD34
2 (LSKFlk2
2CD34
2) LT-HSC-enriched
cell population [44] (2-fold, p,0.01) in the BM. Correlating with
this was an expansion of the ST-HSC enriched LSKFlk2
2CD34
+
cells, MPP-enriched LSKFlk2
+ and LSK populations of cells
(p,0.001) (Figure 2A and 2B), indicating that all primitive
hematopoietic cells were significantly increased upon acute
hematopoietic Grp94 deletion. These findings, coupled with the
observation that the total BM cell number was not significantly
different in the mutant mice (p=0.373) (Figure 2C), reveal that the
total number of primitive hematopoietic cells in cKO mice BM is
higher compared to controls. We also analyzed the progenitor cell
populations in the BM. While the common myeloid progenitor
(CMP) enriched Lin
2 c-Kit
+ Sca-1
2 IL-7Ra
2 CD34
+ FccII/
IIIR
lo cells, the common lymphoid progenitor (CLP) enriched
Lin
2 c-Kit
lo Sca-1
lo IL-7Ra
+ cells, and the megakaryocyte-
erythroid progenitor (MEP) enriched Lin
2 c-Kit
+ Sca-1
2 IL-
7Ra
2 CD34
2 FccII/IIIR
lo cells were all comparable between the
cKO mice and their WT littermates, there were significantly more
granulocyte-monocyte progenitor (GMP) enriched Lin
2 c-Kit
+
Sca-1
2 IL-7Ra
2 CD34
+ FccII/IIIR
high cells in the cKO mice
(Figure 3A). This correlates with the increased number of colonies
(p,0.01 for total colony number; p,0.05 for CFU-G and CFU-
GM; p=0.07 for CFU-M) formed by unfractioned cKO BM cells
in CFC assays (Figure 3B).
To examine the underlying cause for the increase in primitive
hematopoietic cells in the BM of the cKO mice, we analyzed the
cell cycle distribution in LSK cells by Hoechst/Pyronin Y staining
Figure 2. GRP94 deficiency in the bone marrow expanded the primitive cell pool. A) Representative flow cytometric analysis with BM cells
using Lin, c-Kit, Sca-1, Flk2 and CD34. B) Quantitation of flow cytometric analysis of primitive cell proportions. Left panel shows the percentage of
LSKFlk2
2CD34
2 in BM and right panel shows LSKFlk2
2CD34
+, LSKFlk2
+ (n=5 for WT, n=8 for cKO) and total LSK (n=16 for WT, n=22 for cKO) cells in
BM using Lin, c-Kit, Sca-1. C) Total BM cell number from WT (n=19) and cKO (n=20) mice (p=0.373). All data are presented as mean 6 s.e., **p,0.01,
***p,0.001.
doi:10.1371/journal.pone.0020364.g002
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genotypes were in G1 phase, the proportion of cells in G0
decreased from 15% in the control to 7.7% in the cKO mice
(p,0.001), whereas the amount of S+G2+M cells increased from
10% in the control to 17% for cKO mice (p,0.01) (Figure 4B).
Furthermore, the expansion of the Grp94 KO primitive hemato-
poietic cell pool was not a consequence of altered cell survival as
analysis of the level of apoptotic cells using Annexin V did not
reveal significant differences between WT and cKO LSK cells
(p=0.324) (Figure 4C). These findings suggest a loss of quiescence
and increase in proliferation account at least in part for the
primitive hematopoietic cell expansion observed in cKO mice,
similar to what has been shown using other models of HSC
function [45].
Grp94 KO HSCs display increased mobilization and
impaired HSC-niche interaction
We next examined whether the alteration in the cell cycle status
of the primitive hematopoietic cells was accompanied by any
changes in their localization [46]. Histological analysis showed
that the spleen size was significantly enlarged in cKO mice
Figure 3. GRP94 deficiency led to increased granulocyte–monocyte progenitors in the bone marrow. A) Quantitation of flow cytometric
analysis of myeloid and lymphoid progenitors including common myeloid progenitor (CMP), granulocyte-monocyte progenitor (GMP),
megakaryocyte-erythroid progenitor (MEP) and common lymphoid progenitor (CLP) from WT (n$7) and cKO (n$10) mice. B) Quantitation of
colonies formed from unfractioned BM from WT (n=4) and cKO (n=7) mice in methylcellulose medium. All data are presented as mean 6 s.e.,
*p,0.05, **p,0.01.
doi:10.1371/journal.pone.0020364.g003
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hematopoiesis as indicated by the increased hematopoietic cells
in the red pulps (Figure 5C). Flow cytometric analysis showed that
there was a significant increase (2.5-fold, p,0.001) in the
percentage of LSK cells in the spleen of cKO mice compared to
WT mice (Figure 6A). The number of circulating LSK cells in the
peripheral blood of cKO mice were also greatly increased (17-fold,
p,0.001) compared to control (Figure 6B). We also observed
increased Lin
2 Sca-1
2 c-Kit
+ progenitor cells in the peripheral
circulation. These results suggest that primitive cell mobilization
was increased as a consequence of Grp94 deletion.
Since the HSC niche has been proposed to maintain stem cells
in the BM in a quiescent state, we hypothesized that the increase
in proliferation of the Grp94 KO HSCs may have been mediated
by a loss of interaction with the niche, which thus also led to
increased HSC mobilization and enlargement of the spleen by
extramedullary hematopoiesis in cKO mice. Therefore, we
directly examined the capability of Grp94 KO progenitors to
home and lodge in the endosteal niche. To do this, we performed a
competitive lodgment assay (Figure 7A), in which the lodging of
primitive cells is dependent upon their functional interaction with
the niche in vivo. An equal number of WT and cKO Lin
2 c-Kit
+
(LK) cells were labeled with fluorescent vital dyes CFSE and
SNARF respectively, and co-injected into non-irradiated WT
littermates. In these experiments we used LK cells, as in agreement
with previous studies, the use of a purified HSC population would
result in too few cells to be reliably detected [47]. We observed
that fewer labeled cells from mutant mice homed to BM, while
more of them migrated to the spleen of recipient mice (p,0.05)
(Figure 7B and 7C). We cut a total of 180 sections of femurs and
tibias from a total of three recipient mice in three independent
experiments, and visualized the localization of cells as shown in
Figure 7D. The endosteal region is defined as the area within 2 cell
diameters from endosteal surface. Among all the 400–1000 cells
that homed to the BM (numbers varied each time according to the
number of cells injected), about 13.5% of WT LK cells lodged at
the endosteal region, while only 5% of the cKO cells that homed
to the BM were found at the endosteal surface (p,0.05)
Figure 4. GRP94-deficient LSK cells displayed increased proliferation and loss of quiescence. A) Representative flow cytometric analysis
of LSK cell cycle status by Hoechst and Pyronin Y staining. To examine early effects of GRP94 depletion on HSC proliferation, BM was extracted from
WT and cKO mice 3 days after 4 shots of pI.pC injection every other day. B) Summary of cell cycle distribution of LSK cells from WT and cKO mice
(n=7). C) Summary of flow cytometric analysis of apoptotic LSK cells using Annexin V and 7AAD (n=5 for WT, n=8 for cKO) (p=0.324). All data are
presented as mean 6 s.e., **p,0.01, ***p,0.001.
doi:10.1371/journal.pone.0020364.g004
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primitive hematopoietic cells impairs the ability of HSCs to home
to BM and lodge at the endosteal niche. As a consequence, in the
competitive repopulation assay (Figure 8A) cKO LSK cells failed
to engraft and reconstitute the hematopoietic system in lethally
irradiated recipient mice in the presence of WT competitors
(Figure 8B and 8C).
GRP94 in HSCs, but not niche cells, is necessary for
maintaining HSC homeostasis
In the competitive repopulation and competitive lodgment assay,
where cKO cells are transplanted into a WT microenvironment, we
observed impairment in the function of the cells indicating that
Grp94 deletion in HSCs at least partially contributes to the
disruption of the HSC-niche interaction. However, in our model
system Grp94 was knocked out in the whole BM, therefore the
disruption of HSC-niche interactions could also be attributed to the
niche cells. To further explore a possible extrinsic role of GRP94
null niche cells in HSC homeostasis disturbance in cKO mice, we
created a chimeric mouse model with WT hematopoietic cells and a
GRP94 null microenvironment. WT BM cells were transplanted
into lethally irradiated WT or cKO recipient mice. Following 8
weeks to allow for full reconstitution of WT hematopoietic system,
Grp94 deletion was induced by pI.pC administration (Figure 9A).
According to previous reports, BM stromal cells do not engraft after
BM transplantation [48], therefore, Grp94 KO only occurred in the
hematopoietic cells. Chimeras with WT hematopoietic cells and
cKO microenvironment showed a normal hematology profile and
spleen size as WT control chimeras (Figure 9B and 9C). Flow
cytometric analysis revealed a similar LSK percentage in BM from
cKOchimeras and WT controls (Figure9D and 9E). These findings
provide direct evidence that GRP94 in HSCs is required for their
interaction with the niche, and depleting GRP94 in BM
microenvironment itself is not sufficient to affect the regulation of
HSCs.
Grp94 KO HSCs lack cell surface integrin a4 expression
and exhibit impaired binding to fibronectin
To investigate the potential mechanism by which GRP94
maintains the interaction between HSCs and the niche, we
examined the cell surface expression of integrin a4 and a5, which
are known to be important for the homing and adhesion of HSCs
to the endosteal niche [49,50]. Flow cytometric analysis with
mouse BM LSKFlk2
2 and LSKFlk2
+ populations demonstrated
significantly lower expression of cell surface CD49d (integrin a4/
b1) on cKO than WT cells, whereas CD49e (integrin a5/b1)
expression was comparable between the two groups (Figure 10A).
These results establish that GRP94 is required for the expression
of integrin a4 on the cell surface of hematopoietic stem and
progenitor cells, which is consistent with the recent finding that
Figure 5. Increase extramedullary hematopoiesis in the spleen of Grp94 KO mice. A) Representative spleen size and morphology of WT and
cKO mice. B) Average spleen weights of WT (n=19) and cKO (n=25) mice. The data are presented as mean 6 s.e., ***p,0.001. C) Representative H&E
staining of paraffin sections of spleen from WT and cKO mice. Hematopoietic cells in the red pulp are indicated by the area between the two arrows.
Scale bar represents 2 mm.
doi:10.1371/journal.pone.0020364.g005
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cells [40].
To test specific interactions of the primitive hematopoietic cells
with adhesion molecules known to be present at the endosteal
surface and play a role in mediating HSC-niche interactions, we
examined the ability of the cells to bind to fibronectin in vitro, the
binding partner of integrin a4, with binding to BSA as a negative
control. While WT LSK cells were able to bind to fibronectin, we
did not detect binding of the cKO cells to fibronectin above the
negative control level (Figure 10B). Collectively, these findings
demonstrate that acute depletion of GRP94 in HSCs disrupts the
interaction of HSCs with niche, possibly through the disruption of
adhesion to key extracellular matrix molecules mediated by
integrin a4.
Deletion of Grp94 in the hematopoietic system leads to
altered myeloid and lymphoid differentiation
To determine the consequence of acute depletion of GRP94
following Mx-1-Cre induction, we examined the hematopoietic
phenotypes of cKO mice compared to control siblings. Complete
blood count analysis demonstrated a general leukocytosis and
severe thrombocytopenia, while red blood cell and hemoglobin
counts were normal. Monocytes and granulocytes in peripheral
blood were increased 8-fold and 10-fold, respectively, in cKO mice
compared to control mice (Figure 11A), which is consistent with
the increased GMP in the cKO BM (Figure 3A). Analysis of blood
smears further confirmed the leukocytosis in peripheral blood
(Figure 11B). Compared with WT littermates, cKO mice showed
significantly lower thymus and lymph node cellularities
(Figure 11C), consistent with smaller thymus and peripheral
lymph nodes (data not shown). The increase in myeloid cells and
decrease in lymphoid cells corresponded with a higher proportion
of granulocytes and macrophages and a lower proportion of T-
cells and B-cells in the spleen of the cKO mice (Figure 11D and E).
The expansion of myeloid cells was also evident in the BM, where
Gr-1
+ cells were increased and B220
+ cells were decreased in cKO
mice. The proportion of CD4
+ and CD8
+ cells in the BM of cKO
mice were comparable to the control mice (Figure 11F and G).
Discussion
GRP94 is the most abundant glycoprotein in the ER and is
emerging as an important player in protein processing. Its unique
interaction with specific client proteins may allow it to specifically
regulate cellular processes distinct from other major chaperones in
the ER. In particular, recent model studies suggested that GRP94
is critically required for the functional expression of secretory and/
or membrane proteins that enable the integration of cells into
tissues [32]. Here we examined the role of GRP94 in the HSC
interactions with the adult BM niche. The model system that we
Figure 6. Increased mobilization of Grp94 KO HSCs. A) Representative flow cytometric analysis of splenocytes from WT (n=9) and cKO (n=9)
mice using Lin, c-Kit and Sca-1 (left) and quantitation (right). In these studies, splenocytes were extracted from WT and cKO mice 5 days after 7
injections of pI.pC (to examine HSC mobilization before the spleen was enlarged). B) Representative flow cytometric analysis of blood MNCs from WT
(n=11) and cKO (n=10) mice using Lin, c-Kit and Sca-1 (left) and quantitation (right). All data are presented as mean 6 s.e., ***p,0.001.
doi:10.1371/journal.pone.0020364.g006
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can be acutely eliminated largely in the hematopoietic system in a
temporally controlled manner in adult mice. Our results showed
that within 3 weeks of depletion of GRP94 in the hematopoietic
cells, there was a 2-fold increase in primitive HSCs in the mutant
mice. The Grp94 KO LSK cells are more proliferative, likely as a
consequence of loss of niche interaction. The latter is supported by
our observation that the mutant LSK cells are more mobilized to
the spleen and peripheral blood. The mutant LSK cells lack cell
surface integrin a4 expression and do not bind to fibronectin as
efficiently as the WT LSK cells in vitro, are less able to lodge in the
BM niche in vivo, and as a consequence showed no engraftment in
competitive repopulation assays.
The maintenance of HSCs involves the balance between self-
renewal and differentiation, proliferation and quiescence, mobili-
zation and homing, as well as their capacity to provide lifelong
reconstitution of all blood-cell lineages after transplantation into
lethally irradiated recipients [3,12]. Our study demonstrates the
unique function of GRP94 in regulating the homeostasis of HSCs
and their interaction with the stem cell niche. Currently, the
regulation of HSC physiology is mostly attributed to transcription
factors, cell-cycle regulators, chromatin-associated proteins, extra-
cellular signaling molecules and their receptors [1]. Here we
explore the notion that an ER chaperone protein may play a role
in the regulation of HSC-niche interactions. The HSC niche is
believed to house HSCs, maintain their quiescence and prevent
Figure 7. Grp94 KO HSCs displayed impaired interaction with the niche. A) Scheme of the in vivo competitive lodgment assay. B)
Representative flow cytometric analysis of CFSE-labeled WT LK cells and SNARF-labeled cKO LK cells with host BM and spleen cells. C) Summary of LK
cells homed to the BM and spleen (n=4 for BM, n=2 for spleen), with the level of WT cells in BM and spleen set as 1. D) Bone section of a recipient
femur. WT LK cells were labeled with CFSE (green); cKO LK cells were labeled with SNARF (red); and nuclei were stained with DAPI (blue). Solid arrows
indicate cells lodged in the endosteal region (within two cell diameters from the endosteal surface), while open arrows indicate cells located in the
central marrow. Scale bar represents 1 mm. E) Summary of the percentage of labeled LK cells found at the endosteal region among those homed to
BM from 3 independent experiments. All data are presented as mean 6 s.e., *p,0.05.
doi:10.1371/journal.pone.0020364.g007
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primitive cells are less efficient in contacting with BM niche, with
the consequence that the mutant LSK cells can exit quiescence
and enter cell cycle. While the precise mechanisms by which
GRP94 affects this awaits future investigation, one plausible
mechanism may be attributed to the requirement of GRP94 to
facilitate processing of factors such as integrins specifically required
for HSC-niche adhesion [19]. Secretory factors and cell-surface
proteins are synthesized in the rough ER, and translocated into the
ER where they are folded into their functional conformation by
ER chaperone proteins [30]. GRP94 has been reported to be
essential for the proper folding of several integrins, including a4
[40]. This has been reported to mediate the interaction of HSCs
with niche cells and the extracellular matrix, as loss of integrin a4
results in impaired homing and reduced efficiency of HSCs to
lodge to the endosteal surface [19,49]. While integrin a4 and a5
are both important for HSC retention in the niche [17,51],
GRP94 is specifically required for processing integrin a4 but not
a5 in HSCs. The failure of the Grp94 KO HSCs to express
integrin a4 on the cell surface and its inability to bind to
fibronectin are supportive of this notion. It is also possible that
GRP94 is required for the proper folding of soluble ligands
mediating the cross talk from HSCs to the niche. Other
mechanisms may include cell cycle regulation by GRP94 and
the ability of GRP94 to regulate ER Ca
2+ efflux and signaling. As
GRP94 is also recently localized to the cell surface and also
identified as a transmembrane ER protein [30], it may also control
signaling pathways initiated from the cell surface and/or the ER
and cytosol interphase affecting stem cell proliferation.
Our studies raise the general issue concerning the roles of
protein folding chaperones in hematopoiesis and its relationship to
the unfolded protein response (UPR). Hematopoiesis is tightly
regulated by growth factors, cytokines and their receptors, which
are secretory and cell membrane proteins [52]. Secretory factors
Figure 8. Grp94 KO HSCs failed to reconstitute the hematopoietic system in the presence of WT competitors. A) Scheme of the in vivo
competitive repopulation assay. B) Representative flow cytometric analysis with tail blood from recipient mice 4 weeks after BM transplantation.
CD45.1
+ cells represent blood cells from WT competitor, while CD45.2
+ cells represent progenies from WT or cKO LSK cells. Tail blood from recipient
mice 8, 12, and 24 weeks after BM transplantation yielded the same results (data not shown). C) Summary of the percentage contribution of WT or
cKO LSK cells to the peripheral blood MNCs (n=5). The data are presented as mean 6 s.e., ***p,0.001.
doi:10.1371/journal.pone.0020364.g008
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they are folded into their functional conformation by ER
chaperone proteins. Therefore, ER chaperone proteins are likely
to be important for maintaining hematopoiesis, and their function
depends on the role of specific client proteins in hematopoiesis.
Other than synthesizing client proteins that are regulating
hematopoiesis, the ER is also involved in hematopoiesis through
UPR signaling pathways. For example, UPR sensor IRE1
ribonuclease activity for XBP-1 splicing is required for both the
early differentiation of T and B lymphocytes and the terminal
differentiation of activated B cells to immunoglobin-secreted
plasma cells [53,54]. Whether UPR signaling is involved in
Figure 9. Effect of cKO microenvironment on HSC maintenance. A) Scheme of creating chimeric mice with WT hematopoietic cells
transplanted into WT or cKO microenvironment. B) Complete blood count with tail peripheral blood from WT-WT (n=5) and WT-cKO (n=8) chimeric
mice. C) Quantitation of spleen weights from WT-WT (n=4) and WT-cKO (n=5) chimeric mice. D) Representative flow cytometric analysis with BM
from WT-WT and WT-cKO chimeric mice using Lin, c-Kit and Sca-1. E) Summary of percentage of LSK cells in the BM from WT-WT (n=5) and WT-cKO
(n=8) chimeric mice. All data are presented as mean 6 s.e..
doi:10.1371/journal.pone.0020364.g009
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PLoS ONE | www.plosone.org 10 May 2011 | Volume 6 | Issue 5 | e20364regulating HSC homeostasis is not known, and awaits further
investigation.
In comparing our Mx-1-Cre-mediated acute GRP94 KO model
with the chimera model using tamoxifen-inducible GRP94 KO
following BM transplantation [40], similar hematopoietic pheno-
types, including general leukocytosis, increased spleen cellularity,
decreased thymus and lymph node cellularities, increased myeloid
cells and decreased lymphoid cells in the BM and spleen were
observed in both models. The increase of LSK cells in the BM,
spleen and peripheral blood and loss of integrin a4 expression
upon GRP94 depletion are also in agreement with the previous
report [40], which focuses on the role of GRP94 in lymphogenesis,
specifically pro-B to pre-B transition in B cell development, as well
as T cell development beyond CD4
2 CD8
2 double negative stage.
Our work here investigates the unique function of GRP94 in the
homeostasis of HSCs and their interaction with the stem cell niche.
With our model, we provide new evidence that the expansion of
primitive hematopoietic cells is attributed to the change of cell
cycle status upon Grp94 deletion and that the change of HSC cell
cycle status and localization is due to loss of interaction with the
niche, revealed by the impaired homing and lodging ability of
GRP94-deficient HSCs in vivo. We further determined that
GRP94 in the niche cells is not required for maintaining the
interaction with HSCs.
In summary, we identified GRP94 as a novel regulator of HSCs
physiology and their interaction with the niche. It is tempting to
speculate that agents that can alter GRP94 expression or activity
may be explored for therapeutic intervention, such as increasing
the proportion of HSCs in peripheral blood as a source for blood
stem cell therapy, or as an alternative method for non-
myeloablative conditioning through emptying the HSC niche
[55] and these warrant future investigation. Furthermore,
overexpression of GRP94 has been associated with cellular
transformation, tumorigenicity and decreased sensitivity to anti-
cancer treatment [56]. With cancer stem cells implicated as the
cancer initiating cells responsible for tumorigenesis and contribute
to cancer resistance [57], it would be interesting to determine in
future studies whether GRP94 regulates cancer stem cell niche
interaction and thus contributes to tumorigenicity and self renewal
of resistant cancer cells.
Materials and Methods
Ethics statement
All protocols for animal use were reviewed and approved by the
USC Institutional Animal Care and Use Committee. The animal
assurance number is A3518-01. The protocol number is 9964.
Mice
Grp94
F/F mice in a mixed C57BL/6; 129/Sv background were
generated as previously described [42]. Grp94
F/F mice were
crossed with the transgenic Mx-1-Cre mice on a C57BL/6
background (Jackson Laboratory) to generate Grp94
F/F; Mx-1-Cre
mice. Littermates that were negative for Cre transgene were used as
controls. Genotyping was performed by PCR using genomic DNA
extracted from mouse tail biopsies as previously described [58]. To
induce the genomic deletion, 5.5 to 6.5 week-old male and female
mice were injected intraperitoneally with pI.pC (25 mg/g mouse
body weight) every other day. Mice were analyzed 11 days post 7
injections, except with modifications as specifically mentioned in
the figure legends.
Complete blood count
Peripheral blood was collected via tail bleeding and analyzed
using an auto hematology analyzer BC-2800 vet (Mindray,
Redmond, WA) according to manufacturer’s instructions.
Flow cytometry
BM cells were flushed from long bones (tibias and femurs) with
Dulbecco’s phosphate-buffered saline without calcium and
magnesium (DPBS), and then filtered through nylon screen (70
micron, BD Biosciences) to obtain single cell suspension.
Figure 10. Inability of Grp94 KO HSCs to express surface integrin a4 and bind to fibronectin. A) Representative flow cytometric analysis of
CD49d and CD49e with BM LSKFlk2
2 and LSKFlk2
+ cells from WT and cKO mice. Grey-filled histogram represents isotype control staining; dashed
green line represents WT cells; solid red line indicates cKO cells. B) The percentage of WT and cKO LSK cells bound to fibronectin in vitro. The number
of cells binding to BSA was subtracted from that binding to fibronectin, the results then were normalized against the number of WT cells bound to
BSA. The experiments were performed twice in duplicate; each replicate contained pooled BM from 2 to 4 WT or cKO mice. The data are presented as
mean 6 s.e..
doi:10.1371/journal.pone.0020364.g010
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PLoS ONE | www.plosone.org 11 May 2011 | Volume 6 | Issue 5 | e20364Splenocytes were collected following disaggregation of the spleens
in DPBS, with red blood cells (RBCs) lysed in lysing buffer (BD
Biosciences) for 15 min and then filtered through nylon screen to
obtain single cell suspension. Peripheral blood samples were
collected by tail bleeding, with RBCs lysed in lysing buffer twice
for 15 min. Cells from mouse tissue [BM, spleen and peripheral
blood mononuclear cells (MNCs)] were resuspended in DPBS with
0.5% BSA and 0.1% sodium azide for antibody staining. To study
hematopoietic stem and progenitor cells, Lineage (Lin) which
consists of B220 (RA3-6B2), TER119 (TER119), CD4 (RM4-5),
CD8a (53-6.7), Gr-1 (RB6-8C5), and Mac-1 (WT.5), c-Kit (2B8),
Sca-1 (D7), Flk2 (A2F10.1) CD34 (RAM34), IL7Ra (SB/199) and
FccRII/III (2.4G2, all antibodies from BD Pharmingen) were
used. To study different lineages of blood cells, Gr-1, F4/80
(Invitrogen), B220, CD4, CD8a and CD3 (1F4) were used.
CD45.1 (A20) and CD45.2 (104, both from BD Pharmingen) were
used for BM transplantation analysis. Integrin a4 and a5 were
detected using CD49d (R1-2, eBioscience) and CD49e (5H10-27,
BD Pharmingen). 3610
6-1610
7 BM or spleen cells, or MNCs
from 200 mL peripheral blood were incubated with antibodies for
30 min, washed twice with DPBS with 0.5% BSA and 0.1%
sodium azide, and then resuspended in DPBS. Dead cells were
excluded by 7AAD staining (BD Pharmingen). Cell population
analysis was performed on BD FACS LSR II.
Fluorescence activated cell sorting
Mouse whole BM cells resuspended in DPBS were enriched for
c-Kit
+ cells using CD117 MicroBeads (Miltenyi Biotec, Auburn,
CA) according to manufacturer’s instructions. c-Kit
+ cells were
stained with anti-mouse c-Kit (Miltenyi Biotec), anti-mouse Sca-1,
and Lin antibody cocktail as described above. Primitive hemato-
poietic stem and progenitor cells were purified using a FACSAria
flow cytometer (Becton Dickinson) based on established cell
surface phenotypes. LSK cells were sorted for the competitive
repopulation and adhesion assays; LK cells were purified for the in
vivo homing and lodgment assay.
Cell cycle analysis
1610
7 whole BM cells were incubated with 10 mg/ml Hoechst
33342 (Sigma-Aldrich) at 37uC for 45 min, then stained with
primitive hematopoietic cell antibodies (Lin, c-Kit and Sca-1) as
described above. The stained cells were resuspended in 10%
neutral buffered formalin (BDH Chemicals) and incubated at 4uC
overnight. To stain for RNA content, Pyronin Y (Polysciences
Figure 11. Grp94 KO mice displayed altered myeloid and lymphoid differentiation. A). Complete blood count of peripheral blood from WT
(n=31) and cKO (n=37) mice. B) Representative Wright-Giemsa staining of blood smear with tail peripheral blood from WT and cKO mice. Scale bar
represents 500 mm. C) Total thymus cell number (left) and total left and right axillary lymph nodes cell number (right) from WT and cKO mice (n=7 for
each group). D) Representative flow cytometric analysis of splenocytes from WT and cKO mice using lineage markers Gr-1 and CD3 (left), F4/80 and
B220 (right). E) Quantitation of (D) from WT (n=4) and cKO (n=7) mice. F) Representative flow cytometric analysis with BM cells using lineage
markers Gr-1 and B220 (left) and CD4 and CD8a (right). G) Quantitation of (F). Gr-1 and B220 (n=7 for WT and n=9 for cKO mice); CD4 and CD8a
(n=7 for each genotype). All data are presented as mean 6 s.e., ***p,0.001.
doi:10.1371/journal.pone.0020364.g011
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concentration of 0.75 mg/ml and incubated at 4uC for 30 min.
Cell cycle status was examined using a BD LSR II flow cytometer.
Apoptosis assay
1610
6 whole BM cells were stained with primitive hematopoi-
etic cell antibodies (Lin, c-Kit and Sca-1) as described above. The
stained cells were resuspended in 150 mL1 6Annexin V binding
buffer (BD Pharmingen) and incubated with Annexin V and
7AAD (both from BD Pharmingen) for 15 min. Cell apoptosis was
examined within an hour using a BD LSR II flow cytometer.
Colony-forming cell (CFC) assay
Freshly isolated BM cells were mixed thoroughly with 300 mL
Iscove’s MDM with 2% FBS and 4 mL defined methylcellulose
medium M3434 (StemCell Technologies). Cells were then plated
in triplicate in six-well plates with 1.1 mL volume at a density of
1610
4 BM cells per well. The colonies were then scored at day 10
under an inverted microscope and reported as colony number in
specific lineages according to the morphology of colonies described
in the manufacturer’s instructions.
Real-time quantitative RT-PCR
To detect Grp94 knockout efficiency, RNA was extracted from
mouse whole BM cells and reverse-transcription was performed as
previously described [59]. cDNA samples were analyzed in
triplicate with the SYBR Green Supermix (Quanta Biosciences,
Gaithersburg, MD) according to manufacturer’s instructions. The
following primers were used: Grp94,5 9-TGG GCC TCT GCT
GTG TCC TGC-39 and 59-GGC TTT TAC CCA GGT CCT
CTT CCA CTG T-39; 18S RNA,5 9-ACG GCC GGT ACA GTG
AAA C-39 and 59-GAG GGA GCT CAC CGG G-39.
Competitive repopulation assay
LSK cells were sorted using a FACSAria flow cytometer and
1000 WT or cKO LSK cells (CD45.2) were mixed with 250,000
BM MNCs (CD45.1) which is equivalent to approximately 500
LSK cells, and injected into the tail vein of B6.SJL mice that were
lethally irradiated at 9.5Gy approximately 24 hr prior to
transplantation. Engraftment levels and multilineage reconstitu-
tion were measured in peripheral blood samples obtained from the
tail vein of hosts starting week 4.
In vivo homing
Sorted WT and cKO Lin
2 c-Kit
+ (LK) cells (,5610
5 to 1610
6)
were labeled with a green fluorescent dye, carboxyfluorescein
diacetate succinimidyl ester (CFSE), and a red fluorescent dye,
SNARF-1 (both from Invitrogen), respectively, according to
manufacturer’s instructions. Labeled cells were injected into the
tail vein of non-irradiated Grp94
F/F C57BL6; 129/Sv background
littermates. Mice were then sacrificed after 16 hr, and the number
of labeled cells was measured in the BM and spleen through the
detection of CFSE
+ and SNARF
+ cells by flow cytometry.
In vivo lodgment
LK cells were labeled with 5 mM CFSE or 5 mM SNARF cell-
labeling solutions and injected into the tail vein of non-irradiated
mice, as described above. Tibias and femurs were dissected from
recipient mice 16 hr after injection, decalcified for 3 days in
Immunocal (Decal Chemical Corporation, Tallman, NY), and
embedded in paraffin blocks after processing. A total of 180 bone
sections of 5 mm thickness from three recipients were cut and
mounted with Vectashield containing 49,6-diamidino-2-phenylin-
dole (DAPI) (Vector Laboratories, Burlingame, CA). To assess the
lodgment of injected cells to the endosteal niche, the numbers of
CFSE
+ (green) or SNARF
+ (red) cells within two cell diameters
from the endosteal surface were counted.
Adhesion assay
5610
2 LSK cells were added to wells coated with fibronectin
(1.5 mg/cm
2, BD Biosciences, Bedford, MA) in cell culture treated
96-well plates and incubated in minimum essential medium
(MEM) alpha medium with 10% FBS for 3 hr at 37uC/5% CO2
in a humidified atmosphere. Non-adherent cells were washed off
with DPBS and adherent cells were visually counted microscop-
ically. To control for nonspecific binding, adhesion to 1% bovine
serum albumin (Sigma-Aldrich) was quantified.
Statistics
Statistical significance was assayed by Student’s t test.
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